Stockholm, April 23, 2025 - Vicore Pharma Holding AB (STO: VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced that the Company ...
MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy ...
A summary of the presentations and findings of the International Conference on Nutrition in Medicine (ICNM), the annual ...
EDINBURGH, United Kingdom, Sept. 18, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NCNA) announced four presentations at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer ...
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural ...
Interested contributors now have until 19 May 2025 to submit abstracts for the IAEA's International Conference on Emergency Preparedness and Response. The conference will be held from 1 December to 4 ...
There are many venues in which to present your research findings, both within BCM and at external conferences. Your research mentor is likely to be an excellent source of information regarding ...
NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) presents scientific updates in presentations selected for European and American conferences ...
The conference will be held as an in-person event, with the possibility of remote connection, if needed. There is no deadline for registration of participants without a paper submission or grant ...
Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPF Additional presentations include preclinical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results